Company · CIK 711377

# NEOGEN CORP

| CIK | [711377](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000711377) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2835 — In Vitro & In Vivo Diagnostic Substances |
| Incorporated in | MI |
| Business address | MI |
| Listed | NEOG (Nasdaq) |
| First annual or quarterly report | 1998-10-13 |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-133614 | Shelf Dormant | 2006-04-27 | 2006-04-27 | 1 |

## Filings

 2

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2022-08-04 | [EFFECT](https://www.sec.gov/Archives/edgar/data/711377/999999999522002248/9999999995-22-002248-index.htm) Declared effective | 333-263667 | 9999999995-22-002248 |
| 2006-04-27 | [S-3](https://www.sec.gov/Archives/edgar/data/711377/000119312506091230/0001193125-06-091230-index.htm) Shelf registered | 333-133614 | 0001193125-06-091230 |

[All filings of this company](https://equitycapital.markets/filings?cik=711377) · [CSV](https://equitycapital.markets/filings.csv?cik=711377)

---
Source page: https://equitycapital.markets/company/711377 · Data: U.S. SEC EDGAR · CC BY 4.0